Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Tesla is Back: Why the Stock Could Be a Top Winner in 2026
Tesla is Back: Why the Stock Could Be a Top Winner in 2026

I have said it before and I’ll say it again: Tesla stock moves in manic cycles of booms and busts. Right now, it is firmly back in boom mode.

After a difficult couple of years, marked by shrinking

5 Shoes & Retail Apparel Stocks to Watch as Cost Pressures Persist
5 Shoes & Retail Apparel Stocks to Watch as Cost Pressures Persist
Companies in the Zacks Shoes and Retail Apparel industry continue to grapple with persistent pressures. Higher input and freight costs, lingering supply-chain inefficiencies, and elevated SG&A tied
Oracle Q2 Earnings Beat Estimates, Cloud Growth Fuels Revenue Rise
Oracle Q2 Earnings Beat Estimates, Cloud Growth Fuels Revenue Rise

Oracle ORCL reported second-quarter fiscal 2026 non-GAAP earnings of $2.26 per share, which beat the Zacks Consensus Estimate pegged by 38.65% and surged 54% year over year in USD and 51% in

Reasons Why You Should Hold Booz Allen Stock in Your Portfolio
Reasons Why You Should Hold Booz Allen Stock in Your Portfolio

Shares of Booz Allen Hamilton Holding Corporation BAH have gained 4.6% over the past month against 0.4% decline of the Industry.

The company has a Growth Score of A. This style score condenses key

Are You Looking for a High-Growth Dividend Stock?
Are You Looking for a High-Growth Dividend Stock?

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is

Reasons Why Investors Should Bet on Rollins Stock Right Now
Reasons Why Investors Should Bet on Rollins Stock Right Now

Rollins, Inc. ROL, a provider of pest and termite control services, has performed decently over the past three months and has the potential to sustain the momentum in the near term. Consequently, if

Franklin vs. T. Rowe Price: Which Asset Manager Has the Edge for 2026?
Franklin vs. T. Rowe Price: Which Asset Manager Has the Edge for 2026?

Franklin Resources, Inc. BEN and T. Rowe Price Group, Inc. TROW are long-established global asset managers with broad investment platforms across equities, fixed income, multi-asset, and

FE or AEP: Which Is the Better Value Stock Right Now?
FE or AEP: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Utility - Electric Power sector have probably already heard of FirstEnergy (FE) and American Electric Power (AEP). But which of these two stocks is more

UVV or BTI: Which Is the Better Value Stock Right Now?
UVV or BTI: Which Is the Better Value Stock Right Now?

Investors with an interest in Tobacco stocks have likely encountered both Universal Corp. (UVV) and British American Tobacco (BTI). But which of these two stocks offers value investors a better bang

PRDO vs. LOPE: Which Stock Is the Better Value Option?
PRDO vs. LOPE: Which Stock Is the Better Value Option?

Investors interested in stocks from the Schools sector have probably already heard of Perdoceo Education (PRDO) and Grand Canyon Education (LOPE). But which of these two companies is the best option

ADUS or USPH: Which Is the Better Value Stock Right Now?
ADUS or USPH: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more

ETOR or MMC: Which Is the Better Value Stock Right Now?
ETOR or MMC: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Insurance - Brokerage sector have probably already heard of eToro Group Ltd. (ETOR) and Marsh & McLennan (MMC). But which of these two companies is the best

GAP vs. DECK: Which Stock Is the Better Value Option?
GAP vs. DECK: Which Stock Is the Better Value Option?

Investors with an interest in Retail - Apparel and Shoes stocks have likely encountered both Gap (GAP) and Deckers (DECK). But which of these two stocks offers value investors a better bang for

CGAU or AEM: Which Is the Better Value Stock Right Now?
CGAU or AEM: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Mining - Gold sector have probably already heard of Centerra Gold Inc. (CGAU) and Agnico Eagle Mines (AEM). But which of these two stocks presents investors

JHG or KKR: Which Is the Better Value Stock Right Now?
JHG or KKR: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Financial - Investment Management sector have probably already heard of Janus Henderson Group plc (JHG) and KKR & Co. Inc. (KKR). But which of these two

2026 Comeback Picks: 3 S&P Laggards Poised to Break Out: https://www.marketbeat.com/logos/articles/med_20251210152909_these-2025-losers-are-poised-to-break-out-in-2026.png
2026 Comeback Picks: 3 S&P Laggards Poised to Break Out

There are no sure things in investing. However, reliable patterns can help investors make informed decisions. One such pattern is that stocks that underperform a market index in one year tend to

Why Is Amdocs (DOX) Up 1.3% Since Last Earnings Report?
Why Is Amdocs (DOX) Up 1.3% Since Last Earnings Report?

It has been about a month since the last earnings report for Amdocs (DOX). Shares have added about 1.3% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the

Vail Resorts Q1 Earnings Surpass Estimates, Revenues Miss
Vail Resorts Q1 Earnings Surpass Estimates, Revenues Miss

Vail Resorts, Inc. MTN reported mixed first-quarter fiscal 2026 results, with earnings beating the Zacks Consensus Estimate. However, revenues missed the estimate but increased from the prior year's

GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer
GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer

GSK plc GSK announced that the FDA has granted Orphan Drug Designation to GSK’227, its investigational B7-H3-targeted antibody-drug conjugate (“ADC”), for the treatment of small-cell lung cancer

NEE Stock Trades at Premium Value: Should You Buy, Hold or Sell?
NEE Stock Trades at Premium Value: Should You Buy, Hold or Sell?

NextEra Energy’s NEE shares are trading at a forward 12-month price/earnings (P/E) ratio of 20.56X, a premium compared with the Zacks Utility - Electric Power industry’s average of 14.75X. NEE’s

V Gains Loyalty Edge as Collinson & On-us Unlock 1,800+ Airport Perks
V Gains Loyalty Edge as Collinson & On-us Unlock 1,800+ Airport Perks

Visa Inc. V is sharpening its competitive edge in the Asia Pacific region with a new collaboration between Collinson International and On-us that aims to provide seamless access to over 1,800

CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock?
CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock?

Shares of CorMedix CRMD have witnessed a strong surge so far this year, primarily driven by the continued strong uptake of the company’s lead marketed therapy, DefenCath (Taurolidine + Heparin). The

FEAM Progresses With LCD Glass Tank Trial Commencement by Customer
FEAM Progresses With LCD Glass Tank Trial Commencement by Customer

5E Advanced Materials, Inc. FEAM, popularly known as 5E, recently announced that its customer, a major U.S.-based LCD glass manufacturer, has begun glass furnace testing using the first batch of its

Zacks Initiates Coverage of Hour Loop With Neutral Recommendation
Zacks Initiates Coverage of Hour Loop With Neutral Recommendation

Zacks Investment Research has recently initiated coverage of Hour Loop, Inc. HOUR with a Neutral recommendation, marking the firm’s first-ever analyst report on the microcap e-commerce player. The

Trade Deficit Comes in Lowest in Five Years
Trade Deficit Comes in Lowest in Five Years

The good news just keeps coming this week for the stock market. Following a Fed meeting that cut rates -25 basis points (bps), raised growth estimates and lowered inflation projections, Weekly